On this page you will find advice for HCPs issued during the Covid-19 pandemic.
The following advice draws together information from a number of sources as well as advice issued by the BAD, and will be updated regularly as the situation evolves. The links below are selected highlights of the information available: Please also see the navigation on the left for links to different sections.
Public Advice from BAD (links open at www.skinhealthinfo.org.uk):
Covid-19 (Coronavirus): Statement on dry skin and frequent handwashing to reduce Covid-19 risk
Covid-19 (Coronavirus): Immunosuppresive treatments in dermatology (see below for advice for HCPs)
COVID-19 (Coronavirus): Guidance for dermatology patients for remote consultations (see below clinical guidelines for HCPs)
Updates for Dermatology HCPs from BAD (please also see left-hand navigation for further options):
Dermatology: Response to and Lessons Learnt during the COVID-19 Pandemic
COVID-19 Initial Advice for Dermatology Departments, 19.03.2020
Submission to RCP on time-dependent referrals, diagnoses and interventions for major & common skin disorders 17.04.2020
Guidance on the recommencing of dermatology services during Covid-19
Dermatology Advice Regarding Self-Isolation and Immunosuppressed Patients: Adults, Paediatrics and Young People
COVID-19: Clinical guidelines for the management of dermatology patients remotely
COVID-19: BAD Information for Trainees and Trainers (Dermatology) - this includes information on recruitment, the curriculum, JRCPTB guidance on COVID and trainee progress, and academic guidance
COVID-19: Clinical Guidance for the Management of Skin Cancer Patients during the Coronavirus Pandemic
COVID-19: Guidance For Managing Patients On Isotretinoin During the Coronavirus Pandemic
COVID-19: Guidance For Managing Urticaria Patients on Omalizumab During the Coronavirus Pandemic
BAD Annual Meeting advice
British Association of Dermatologists' Position Statement on the Risk of Cancer from Viral Particles in Surgical Plume
Updates for HCPs from NHS, government, and medical organisations:
1. Personal Protective Equipment (PPE)
British Society for Cutaneous Allergy (BSCA) / BAD update on PPE related dermatitis.
2. Advice on working outside your normal practice, including medical indemnity, advice for private practice, retired members and pregnant workers.
3. NHSE - Frequently Asked Questions (FAQs) for Clinicians, caring for people at highest clinical risk during COVID-19
NHS England has published FAQs for clinicians, answering many common questions about caring for those at highest risk during COVID-19, this is available here: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/20200403-Clinician-FAQs-v_FINAL.pdf
4. Advice from devolved nations:
Health Protection Scotland guidance can been found here: https://www.hps.scot.nhs.uk/guidance/
All COVID-19 specific guidance can be found by searching for 'Covid-19'.
Wales-specific guidance is likely to published by Public Health Wales: https://phw.nhs.wales/
The Public Health Agency is likely to publish Northern Ireland-specific guidance: https://www.publichealth.hscni.net/
5. BMA answers questions on COVID-19
The BMA has answered questions about the impact of COVID-19 on HCP work, training, education, and wellbeing as a medical professional. https://www.bma.org.uk/advice-and-support/covid-19
6. Ethical guidance published for frontline staff dealing with pandemic
The Royal College of Physicians has published ethical guidance for frontline staff dealing with the COVID-19 pandemic, supported by more than a dozen other health organisations. https://www.rcplondon.ac.uk/news/ethical-guidance-published-frontline-staff-dealing-pandemic
7. Information on training, research and education
This section includes:
i) Information for Dermatology trainees and trainers
ii) Free access to research
iii) DHSC guidance on the impact of COVID-19 on research funded or supported by NIHR
iv) HEE E-Learning for Health: Coronavirus programme
8. Covid-19 statements from patient support groups
UK Mastocytosis Support Group: https://ukmasto.org/COVID-19/
UK and Ireland Vasculitis Society (UKIVAS): https://ukivas.ndorms.ox.ac.uk/
The Psoriasis Association: https://www.psoriasis-association.org.uk/psoriasis-and-treatments/covid-19-information
9. Looking after your health and wellbeing during the coronavirus outbreak
The NHS has launched a mental health hotline as part of a package of measures to support the NHS staff as they help people deal with the coronavirus. A free support phoneline, running between 7am and 11pm, staffed by volunteers will be available on 0300 131 7000. A 24 hour text service alternative will also be running, NHS staff can simply text FRONTLINE to 85258. The NHS has also partnered with Headspace, UnMind and Big Health to offer a suite of apps for no charge to assist staff with their mental health. More information is available here.
Dr Tony Bewley and Dr Elise Kleyn have developed a document providing advice to HCPs on 'Coping with the Covid-19 Pandemic'. This covers self-care advice, information, and resources.
Advice for looking after your health and wellbeing during the coronavirus outbreak has been provided by Dr Elise Kleyn, Salford Royal NHS Foundation Trust, and colleagues.
10. Dermatology Covid-19 registries
The BAD is collating information about cutaneous signs or complications potentially associated with Covid-19, both in adults and children: https://www.surveymonkey.co.uk/r/C-19-Dermatology.
The survey is aimed at HCPs who have encountered a patient with confirmed or suspected Covid-19 who has also displayed a new-onset rash or skin symptoms NOT attributable to a pre-existing or known skin disease or other viral disease. We will be sharing anonymised data as required with government agencies dealing with the pandemic, and data may be published. The survey is brief, details provided can be retrospective, and no photos or patient identifiers are required.
The American Academy of Dermatology (AAD) has created a dermatology COVID-19 registry to understand dermatologic manifestations of the COVID-19 virus. The survey is for all healthcare professionals taking care of COVID-19 patients who develop dermatologic manifestations, or dermatology patients with an existing condition who then develop COVID-19.
A study from Spanish researchers, published in the British Journalist of Dermatology, has already identified five common COVID-19 skin symptoms. This study can be found here.
Other dermatology COVID-19 registries include:
PsoProtect: The Psoriasis Registry for outcomes, therapy and epidemiology of COVID-19 Infection.
PsoProtectMe: A registry for psoriasis patients to self report to, whether or not they have had symptoms of COVID-19
The Global Hidradenitis Suppurativa Registry: An international pediatric and adult database to monitor and report outcomes of COVID-19 occurring in hidradenitis suppurativa (HS) patients. This registry includes separate reporting for Healthcare Professionals and self-reporting for patients.
SecureAD: Given the interest in the emerging and evolving coronavirus (COVID-19) pandemic and the questions regarding how this will impact patients with atopic dermatitis (AD, syn. atopic eczema), the SecureAD team have created a secure, online, de-identified Personal Health Identifier (PHI)-free reporting registry.
SecureAlopecia: Given the interest in the emerging and evolving coronavirus (COVID-19) pandemic and the questions regarding how this will impact patients with alopecia (including alopecia areata and other alopecias) who are treated with systemic immunomodulating medication, the SecureAlopecia team have created a secure, online, de-identified Personal Health Identifier (PHI)-free reporting registry.
11. Hosted by the Royal College of Radiologists: Non-melanoma skin cancer and Covid-19
This document provides guidance for the management of NMSC patients in radiology departments.
12. Virtual and informal peer support network
Members of the British Association of Dermatologists are being invited to join an informal peer-support network to help cope with specific issues and the demands that may affect healthcare workers within the NHS during the current Covid-19 pandemic. Further information can be found here.